See how well you did on Pharmaceutical Executive's 25th anniversary quiz.
1. Titanic. Source: www.imdb.com
2. Bambi. The Wizard of Oz and From Here to Eternity were not blockbusters.
Source: www.imdb.com
3. Donald Rumsfeld, Secretary of Defense, was president of G.D. Searle and Co.
Mitchell E. Daniels, former director of the Office of Management and Budget, was once President of North American Operations at Eli Lilly and Co. He is currently Governor of Indiana. Source: www.in.gov
4. e. Ocean's Twelve. Source: www.brandchannel.com
5. Eli Lilly and Co. James C. Quayle appointed Bush to the board of directors. Mr. Quayle's son, Dan, became Mr. Bush's running mate and was elected Vice President in 1988.
6. The line is spoken by an intruder who breaks into the home of the character played by Jodie Foster in the 2002 film, Panic Room. Source: www.brandchannel.com
7. The New England Patriots defeated the Carolina Panthers 32-29. Jackson sang Rock Your Body with Justin Timberlake.
8. Rush Limbaugh has been in the news for his use of oxycodone and Viagra. He has not yet become a spokesman for a medication.
9. Rock Hudson died in 1985.
10. "Betty Davis Eyes," sung by Kim Carnes, won "Song of the Year." Source: www.grammy.com
Chariots of Fire was voted best picture. Source: www.theoscarsite.com
11. 1,g; 2,a; 3,f; 4,d; 5,b; 6,c; 7,e.
Source: www.brandchannel.com
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.